J. David Joyner's Insider Trades & SAST Disclosures
J. David Joyner's most recent trade in CVS Health Corp was a trade of 226,138 Stock Option done . Disclosure was reported to the exchange on April 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern J. David Joyner.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CVS Health Corp | J. David Joyner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 226,138 | 226,138 | - | - | Stock Option | |
| CVS Health Corp | J. David Joyner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 53,324 | 82,515 | - | 0 | Common Stock (RSUs) | |
| CVS Health Corp | J. David Joyner | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.98 per share. | 01 Apr 2025 | 1,847 | 51,940 (0%) | 0% | 68.0 | 125,559 | Common Stock |
| CVS Health Corp | J. David Joyner | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.72 per share. | 28 Feb 2025 | 1,944 | 46,717 (0%) | 0% | 65.7 | 127,760 | Common Stock |
| CVS Health Corp | J. David Joyner | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2024 | 1,492,537 | 1,492,537 | - | - | Premium Stock Option | |
| CVS Health Corp | Joyner J. David | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2024 | 1,000,000 | 1,000,000 | - | - | Premium Stock Option | |
| CVS Health Corp | Joyner J. David | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2024 | 492,537 | 492,537 | - | - | Premium Stock Appreciation Right | |
| CVS Health Corp | J. David Joyner | EVP&President-PharmacyServices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 28,280 | 44,241 | - | 0 | Common Stock (Restricted) | |
| CVS Health Corp | J. David Joyner | EVP&President-PharmacyServices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.19 per share. | 28 Feb 2024 | 1,970 | 40,681 (0%) | 0% | 75.2 | 148,124 | Common Stock |
| CVS Health Corp | J. David Joyner | EVP&President-PharmacyServices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 51,959 | 51,959 | - | - | Stock Option | |
| CVS Health Corp | J. David Joyner | EVP&President-PharmacyServices | Grant, award, or other acquisition of securities at price $ 83.54 per share. | 28 Feb 2023 | 23,940 | 23,940 | - | 83.5 | 1,999,948 | Common Stock (Restricted) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges